Apremilast in patients with history of malignancy: a real-life, single-center experience

Int J Dermatol. 2021 Jan;60(1):e22-e24. doi: 10.1111/ijd.15093. Epub 2020 Aug 28.

Authors

Vito Di Lernia¹, Dahiana M Casanova¹, Cinzia Ricci¹

Affiliation

¹ Dermatology Unit, Arcispedale Santa Maria Nuova, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

PMID: 32857434
DOI: 10.1111/ijd.15093

No abstract available

Publication types

Letter

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / adverse effects
Humans
Neoplasms*
Psoriasis* / drug therapy
Thalidomide / adverse effects
Thalidomide / analogs & derivatives

Substances

Anti-Inflammatory Agents, Non-Steroidal
Thalidomide
apremilast